Insulet Corporation Common Stock PODD
HEALTHCARE · MEDICAL DEVICESi
Market dataready · fetched 2026-11-13T18:50:35.266Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T18:50:08.698339738Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-13T18:50:00.814535+00:00
Insulet Corporation Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 161.23 | 43.5% | 6.3% | 144.29 | 50.5% | 6.3% |
| 25Δ | 159.44 | 43.2% | 5.3% | 146.12 | 49.0% | 5.4% |
| 30Δ | 158.11 | 43.3% | 4.7% | 147.67 | 48.0% | 4.6% |
| 35Δ | 156.79 | 43.4% | 4.1% | 149.22 | 47.0% | 3.9% |
| 40Δ | 155.46 | 43.5% | 3.5% | 150.60 | 46.2% | 3.3% |
| 45Δ | 154.23 | 43.7% | 3.0% | 151.82 | 45.8% | 2.9% |
| 50Δ | 153.05 | 43.8% | 2.7% | 153.04 | 45.3% | 2.4% |
| 55Δ | 151.88 | 44.0% | 2.3% | 154.27 | 44.9% | 2.0% |
| 60Δ | 150.70 | 44.1% | 1.9% | 155.90 | 47.7% | 1.7% |
| 65Δ | 149.45 | 44.2% | 1.6% | 158.18 | 55.6% | 1.6% |
| 70Δ | 148.09 | 44.1% | 1.3% | 160.94 | 65.0% | 1.5% |
| 75Δ | 146.73 | 44.0% | 1.0% | 165.85 | 80.6% | 1.5% |
| 80Δ | 145.37 | 43.9% | 0.8% | 172.32 | 95.2% | 1.3% |
20Δ
- Pseudo strike
- 161.23
- IV
- 43.5%
- B/E move
- 6.3%
- Pseudo strike
- 144.29
- IV
- 50.5%
- B/E move
- 6.3%
25Δ
- Pseudo strike
- 159.44
- IV
- 43.2%
- B/E move
- 5.3%
- Pseudo strike
- 146.12
- IV
- 49.0%
- B/E move
- 5.4%
30Δ
- Pseudo strike
- 158.11
- IV
- 43.3%
- B/E move
- 4.7%
- Pseudo strike
- 147.67
- IV
- 48.0%
- B/E move
- 4.6%
35Δ
- Pseudo strike
- 156.79
- IV
- 43.4%
- B/E move
- 4.1%
- Pseudo strike
- 149.22
- IV
- 47.0%
- B/E move
- 3.9%
40Δ
- Pseudo strike
- 155.46
- IV
- 43.5%
- B/E move
- 3.5%
- Pseudo strike
- 150.60
- IV
- 46.2%
- B/E move
- 3.3%
45Δ
- Pseudo strike
- 154.23
- IV
- 43.7%
- B/E move
- 3.0%
- Pseudo strike
- 151.82
- IV
- 45.8%
- B/E move
- 2.9%
50Δ
- Pseudo strike
- 153.05
- IV
- 43.8%
- B/E move
- 2.7%
- Pseudo strike
- 153.04
- IV
- 45.3%
- B/E move
- 2.4%
55Δ
- Pseudo strike
- 151.88
- IV
- 44.0%
- B/E move
- 2.3%
- Pseudo strike
- 154.27
- IV
- 44.9%
- B/E move
- 2.0%
60Δ
- Pseudo strike
- 150.70
- IV
- 44.1%
- B/E move
- 1.9%
- Pseudo strike
- 155.90
- IV
- 47.7%
- B/E move
- 1.7%
65Δ
- Pseudo strike
- 149.45
- IV
- 44.2%
- B/E move
- 1.6%
- Pseudo strike
- 158.18
- IV
- 55.6%
- B/E move
- 1.6%
70Δ
- Pseudo strike
- 148.09
- IV
- 44.1%
- B/E move
- 1.3%
- Pseudo strike
- 160.94
- IV
- 65.0%
- B/E move
- 1.5%
75Δ
- Pseudo strike
- 146.73
- IV
- 44.0%
- B/E move
- 1.0%
- Pseudo strike
- 165.85
- IV
- 80.6%
- B/E move
- 1.5%
80Δ
- Pseudo strike
- 145.37
- IV
- 43.9%
- B/E move
- 0.8%
- Pseudo strike
- 172.32
- IV
- 95.2%
- B/E move
- 1.3%
Options history
Table
| Date | IV (%) |
|---|---|
| 48.75% | |
| 48.94% | |
| 49.74% | |
| 48.78% | |
| 48.73% | |
| 50.22% | |
| 49.57% | |
| 50.45% | |
| 50.70% | |
| 51.64% |
Medical Devices
PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. The company is headquartered in Redwood City, California.
More →PROF
Profound Medical Corp. The company is headquartered in Mississauga, Canada.
More →QDEL
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health, eye health,…
More →QSI
Description unavailable
More →QTRX
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research and diagnostics in…
More →RCEL
AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California.
More →